In honor of Father’s Day, the Rock and Roll Hall of Fame’s newest inductee, Quincy Jones, is lending his talent and support to the Prostate Cancer Foundation for a new awareness campaign that will be broadcast in Major League Baseball ballparks throughout June.
With the help of his daughter, actress Rashida Jones (Parks and Rec), the new print, video and radio ads urge men to “Cherish Life’s Special Moments,” and talk to their doctors about prostate screenings. Prostate cancer is the second most common cause of cancer death for men in the U.S., with a death every 16 minutes.
Quincy Jones has enjoyed one of the longest, most successful careers in popular music as a record producer, conductor, arranger, composer, television producer, and trumpeter. As influential to jazz music as to pop, he has been nominated for a record 79 Grammys – and won 27.
“I was excited to shoot this PSA with my father,” said Rashida Jones who currently appears on the hit NBC sitcom, Parks and Recreation. “We have to protect the men we cherish, so please talk to your fathers, your grandfathers, husbands, brothers and sons and make sure they speak to their doctors about this disease and how to reduce their risk.”
This year’s campaign builds on an 18-year tradition with Major League Baseball through an annual Home Run Challenge for Father’s Day. “There are over 2.5 million American men who are surviving prostate cancer this Father’s Day,” said Jonathan W. Simons, MD, president and CEO of the Prostate Cancer Foundation.
“Men are 40 percent less likely than women to have visited a healthcare provider in the past year. But talking to one’s doctor about prostate cancer is critically important,” said the president and CEO of Stand Up To Cancer (SU2C), Sung Poblete, PhD, RN.
To date, SU2C and the Prostate Cancer Foundation have collaborated to fund two Prostate Cancer research Dream Teams, each receiving $10 million over a three-year period. The first SU2C-PCF Prostate Cancer Dream Team is addressing therapeutic interventions for advanced prostate cancer with special emphasis on metastatic disease and delivering near-term patient benefit. The second SU2C-PCF Prostate Cancer Dream Team, also formed in 2012, is targeting adaptive pathways in metastatic treatment-resistant prostate cancer using scientists representing six world-class institutions.
To learn more, visit PCF.org